These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 10200949)
1. Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders? Inui A Mol Med Today; 1999 Feb; 5(2):79-85. PubMed ID: 10200949 [TBL] [Abstract][Full Text] [Related]
2. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome]. Inui A Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993 [TBL] [Abstract][Full Text] [Related]
3. [Recent development in research and management of cancer anorexia-cachexia syndrome]. Inui A Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510 [TBL] [Abstract][Full Text] [Related]
4. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Ramos EJ; Suzuki S; Marks D; Inui A; Asakawa A; Meguid MM Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):427-34. PubMed ID: 15192446 [TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis and treatment of cancer anorexia-cachexia, with special emphasis on aged patients]. Inui A Nihon Ronen Igakkai Zasshi; 2004 Sep; 41(5):460-7. PubMed ID: 15515719 [TBL] [Abstract][Full Text] [Related]
6. Cytokines and cancer anorexia cachexia syndrome. Bennani-Baiti N; Davis MP Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577 [TBL] [Abstract][Full Text] [Related]
7. Cachexia and neuropeptide Y. Morley JE; Farr SA Nutrition; 2008 Sep; 24(9):815-9. PubMed ID: 18725077 [TBL] [Abstract][Full Text] [Related]
8. Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia. Hamerman D J Gerontol A Biol Sci Med Sci; 2002 Aug; 57(8):M511-8. PubMed ID: 12145364 [TBL] [Abstract][Full Text] [Related]
9. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Inui A Cancer Res; 1999 Sep; 59(18):4493-501. PubMed ID: 10493494 [TBL] [Abstract][Full Text] [Related]
10. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612 [TBL] [Abstract][Full Text] [Related]
11. [Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients]. Nauck F; Klaschik E Schmerz; 2004 Jun; 18(3):197-202. PubMed ID: 15221423 [TBL] [Abstract][Full Text] [Related]
12. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383 [TBL] [Abstract][Full Text] [Related]
13. Cachexia and protein-energy wasting in children with chronic kidney disease. Mak RH; Cheung WW; Zhan JY; Shen Q; Foster BJ Pediatr Nephrol; 2012 Feb; 27(2):173-81. PubMed ID: 21298504 [TBL] [Abstract][Full Text] [Related]
14. Cancer anorexia-cachexia syndrome: current issues in research and management. Inui A CA Cancer J Clin; 2002; 52(2):72-91. PubMed ID: 11929007 [TBL] [Abstract][Full Text] [Related]
15. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Brown JK Oncol Nurs Forum; 2002 Apr; 29(3):517-32. PubMed ID: 11979284 [TBL] [Abstract][Full Text] [Related]
16. The cancer anorexia-cachexia syndrome. Nelson KA Semin Oncol; 2000 Feb; 27(1):64-8. PubMed ID: 10697022 [TBL] [Abstract][Full Text] [Related]
17. Modern management of the cancer anorexia-cachexia syndrome. Nelson KA Curr Oncol Rep; 2000 Jul; 2(4):362-8. PubMed ID: 11122866 [TBL] [Abstract][Full Text] [Related]
19. The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome. van Norren K; Dwarkasing JT; Witkamp RF Curr Opin Clin Nutr Metab Care; 2017 Sep; 20(5):396-401. PubMed ID: 28708669 [TBL] [Abstract][Full Text] [Related]